Literature DB >> 21737803

Natural course of perihemorrhagic edema after intracerebral hemorrhage.

Dimitre Staykov1, Ingrid Wagner, Bastian Volbers, Eva-Maria Hauer, Arnd Doerfler, Stefan Schwab, Juergen Bardutzky.   

Abstract

BACKGROUND AND
PURPOSE: There is only limited knowledge on the time course of perihemorrhagic edema (PHE) after intracerebral hemorrhage (ICH). We aimed to investigate the chronological PHE course and its relation to in-hospital mortality in a large retrospective ICH cohort.
METHODS: Patients with supratentorial ICH treated at our institution between 2006 and 2009, who had received at least 3 CT scans in the course of conservative treatment, were included in the present analysis. PHE at Days 1, 2, 3, 4 to 6, 7 to 11, 12 to 16, 17 to 21, and >22 was assessed using a threshold based semiautomatic volumetric algorithm. A chart review was performed to achieve data on duration of stay, ventilation, treatment with external ventricular drains, and in-hospital mortality.
RESULTS: Two hundred nineteen patients aged 69.9±10.5 years with deep (n=103) or lobar (n=116) ICH were included in the study. Mean ICH volume was 35.7±31.5 mL. Mean absolute PHE volume significantly increased from initially 32.6±29.9 mL to 63.7±46.7 mL at Days 7 to 11. No significant changes were observed at later time points. ICH volume was strongly correlated with absolute PHE volume (ρ=0.8, P<0.001) and inversely correlated with relative PHE (ρ=-0.4 to -0.5, P<0.001). Increase in absolute PHE between Days 1 and 3 was significantly predictive for in-hospital mortality (P=0.014, ExpB=1.04).
CONCLUSIONS: PHE develops early after ICH and doubles within the first 7 to 11 days after the initial bleeding event. This additional mass effect may contribute to secondary clinical deterioration and mortality, especially in larger ICH. Because of its inverse correlation with ICH volume, relative PHE may not be suitable for analyses considering the clinical impact of PHE.

Entities:  

Mesh:

Year:  2011        PMID: 21737803     DOI: 10.1161/STROKEAHA.111.618611

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  45 in total

Review 1.  Perihematomal edema: Implications for intracerebral hemorrhage research and therapeutic advances.

Authors:  Magdy Selim; Casey Norton
Journal:  J Neurosci Res       Date:  2018-12-21       Impact factor: 4.164

Review 2.  Modulating the Immune Response Towards a Neuroregenerative Peri-injury Milieu After Cerebral Hemorrhage.

Authors:  Damon Klebe; Devin McBride; Jerry J Flores; John H Zhang; Jiping Tang
Journal:  J Neuroimmune Pharmacol       Date:  2015-05-07       Impact factor: 4.147

3.  High Serum MiR-130a Levels Are Associated with Severe Perihematomal Edema and Predict Adverse Outcome in Acute ICH.

Authors:  Meng-Die Wang; Yong Wang; Yuan-Peng Xia; Jing-Wen Dai; Lin Gao; Si-Qi Wang; Hai-Jun Wang; Ling Mao; Man Li; Shi-Meng Yu; Yan Tu; Quan-Wei He; Guo-Peng Zhang; Lei Wang; Guo-Zheng Xu; Hai-Bo Xu; Ling-Qiang Zhu; Bo Hu
Journal:  Mol Neurobiol       Date:  2015-01-29       Impact factor: 5.590

4.  Temporal changes in perihematomal apparent diffusion coefficient values during the transition from acute to subacute phases in patients with spontaneous intracerebral hemorrhage.

Authors:  Enrico Fainardi; Massimo Borrelli; Andrea Saletti; Silvio Sarubbo; Gloria Roversi; Andrea Bernardoni; Francesco Latini; Cristiano Azzini; Luca Borgatti; Alessandro De Vito; Michele Cavallo; Stefano Ceruti; Arturo Chieregato
Journal:  Neuroradiology       Date:  2012-09-18       Impact factor: 2.804

5.  Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial.

Authors:  Magdy Selim; Lydia D Foster; Claudia S Moy; Guohua Xi; Michael D Hill; Lewis B Morgenstern; Steven M Greenberg; Michael L James; Vineeta Singh; Wayne M Clark; Casey Norton; Yuko Y Palesch; Sharon D Yeatts
Journal:  Lancet Neurol       Date:  2019-03-18       Impact factor: 44.182

Review 6.  The use of targeted temperature management for elevated intracranial pressure.

Authors:  Jesse J Corry
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

Review 7.  Targeting secondary injury in intracerebral haemorrhage--perihaematomal oedema.

Authors:  Sebastian Urday; W Taylor Kimberly; Lauren A Beslow; Alexander O Vortmeyer; Magdy H Selim; Jonathan Rosand; J Marc Simard; Kevin N Sheth
Journal:  Nat Rev Neurol       Date:  2015-01-27       Impact factor: 42.937

8.  Impact of Perihemorrhagic Edema on Short-Term Outcome After Intracerebral Hemorrhage.

Authors:  Bastian Volbers; Wolfgang Willfarth; Joji B Kuramatsu; Tobias Struffert; Arnd Dörfler; Hagen B Huttner; Stefan Schwab; Dimitre Staykov
Journal:  Neurocrit Care       Date:  2016-06       Impact factor: 3.210

Review 9.  Genetic underpinnings of cerebral edema in acute brain injury: an opportunity for pathway discovery.

Authors:  Elayna Kirsch; Natalia Szejko; Guido J Falcone
Journal:  Neurosci Lett       Date:  2020-05-26       Impact factor: 3.046

10.  New avenues for treatment of intracranial hemorrhage.

Authors:  Shruti Sonni; Vasileios-Arsenios Lioutas; Magdy H Selim
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.